Table 2.
Total Number of ACE2-Positive Cells and EMT Score
| Data Sets | Total No. of Cells/Samples | ACE2+ Cells (%) | EMT Score in ACE2+ Cells |
|---|---|---|---|
| Bronchial brushings (GSE131391) | 1146 cells (12 patients) | 54 (4.71) | −0.13 |
| Oral cavity tumors (GSE103322) | 5902 cells (18 tumors) | 87 (1.47) | −0.54 |
| Donor lungs (GSE122960) | 20,000 cells (5 lungs) | 94 (0.47) | −0.52 |
| Fibrotic lungs (GSE122960) | 19,587 cells (8 lungs) | 72 (0.37) | −0.75 |
| Parenchymal lung (GSE130148) | 10,360 cells (3 lungs) | 14 (0.14) | −0.26 |
| PC9 xenograft DMSO treated (GSE138693) | 3766 cells (1 xenograft) | 29 (0.77) | −0.40 |
| PC9 xenograft osimertinib treated (GSE138693) | 2332 cells (1 xenograft) | 0 (0) | N/A |
| Bronchial biopsy/nasal brushing/turbinate (GSE121600) | 12,000 cells (3 specimens) | 4 (0.03) | −0.49 |
EMT, epithelial-to-mesenchymal transition; N/A, not applicable.